Effects of Extended Storage of Chlorhexidine Gluconate and Benzalkonium Chloride Solutions on the Viability of Burkholderia cenocepacia
Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, o...
Saved in:
Published in | Journal of microbiology and biotechnology Vol. 27; no. 12; pp. 2211 - 2220 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
한국미생물·생명공학회
28.12.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1017-7825 1738-8872 |
DOI | 10.4014/jmb.1706.06034 |
Cover
Abstract | Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a "safe use" period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2-10 μg/ml) and BZK (10-50 μg/ml) at sublethal concentrations on six strains of
using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on
strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six
strains with different inoculum sizes (10⁰ -10⁵ CFU/ml), their toxic effects were not changed for 28 days.
strains in diluted CHX and BZK were detectable at concentrations up to 10² CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that
strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products. |
---|---|
AbstractList | Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a “safe use” period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2-10 μg/ml) and BZK (10-50 μg/ml) at sublethal concentrations on six strains of Burkholderia cenocepacia using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on B. cenocepacia strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six B. cenocepacia strains with different inoculum sizes (100 -105 CFU/ml), their toxic effects were not changed for 28 days. B. cenocepacia strains in diluted CHX and BZK were detectable at concentrations up to 102 CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that B. cenocepacia strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products. KCI Citation Count: 0 Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a “safe use” period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2–10 μg/ml) and BZK (10–50 μg/ml) at sublethal concentrations on six strains of Burkholderia cenocepacia using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on B. cenocepacia strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six B. cenocepacia strains with different inoculum sizes (10 0 –10 5 CFU/ml), their toxic effects were not changed for 28 days. B. cenocepacia strains in diluted CHX and BZK were detectable at concentrations up to 10 2 CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that B. cenocepacia strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products. Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a "safe use" period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2-10 μg/ml) and BZK (10-50 μg/ml) at sublethal concentrations on six strains of using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six strains with different inoculum sizes (10⁰ -10⁵ CFU/ml), their toxic effects were not changed for 28 days. strains in diluted CHX and BZK were detectable at concentrations up to 10² CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products. |
Author | LiPuma, John J. Kim, Jeong Myeong Marasa, Bernard S. Lee, Yong-Jin Hussong, David Cerniglia, Carl E. Ahn, Youngbeom |
AuthorAffiliation | 1 Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA 3 Department of Pediatrics & Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA 5 Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA 2 Department of Biological Sciences, Albany State University, Albany, GA 31707, USA 4 ValSource, LLC., Downingtown, PA 19335, USA |
AuthorAffiliation_xml | – name: 5 Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA – name: 3 Department of Pediatrics & Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA – name: 1 Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA – name: 2 Department of Biological Sciences, Albany State University, Albany, GA 31707, USA – name: 4 ValSource, LLC., Downingtown, PA 19335, USA |
Author_xml | – sequence: 1 givenname: Youngbeom surname: Ahn fullname: Ahn, Youngbeom – sequence: 2 givenname: Jeong Myeong surname: Kim fullname: Kim, Jeong Myeong – sequence: 3 givenname: Yong-Jin surname: Lee fullname: Lee, Yong-Jin – sequence: 4 givenname: John J. surname: LiPuma fullname: LiPuma, John J. – sequence: 5 givenname: David surname: Hussong fullname: Hussong, David – sequence: 6 givenname: Bernard S. surname: Marasa fullname: Marasa, Bernard S. – sequence: 7 givenname: Carl E. surname: Cerniglia fullname: Cerniglia, Carl E. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29032643$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002301533$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kctuFDEQRS0URB6wZYm8ZdGDH-1-rFAyGkKkSEgksLWq7eqMMz32yO1GCT_Ab-OeIQiQWJXtuve4VPeUHPngkZDXnC1Kxst399tuwWtWLVjFZPmMnPBaNkXT1OIonxmvi7oR6picjuM9YxUXTfWCHIuWSVGV8oT8WPU9mjTS0NPVQ0Jv0dKbFCLc4fy2XA8hrvHBWeeRXg6TCR4SUvCWXqD_DsMmeDdtD0Jnkd6EYUou-Iz0NK2RfnXQucGlx5l3McXNOgwWowNq0AeDOzAOXpLnPQwjvvpVz8iXD6vb5cfi-tPl1fL8ujCyUakwpQAmK8WtrFC2HbQSS4AalFQKVW94l6-8RglSdIpVnW0bVYIVFjslKnlG3h64PvZ6Y5wO4Pb1LuhN1Oefb6-0EILLqsna9wftbuq2aPO0KcKgd9FtIT7unX93vFtnzjfNhWwF2__25k_Cb-vT_rOgPAhMDOMYsdfGJZjXl4Fu0JzpOWadY9ZzzHofc7Yt_rE9kf9j-Akgjq0P |
CitedBy_id | crossref_primary_10_1016_j_ijmmb_2021_12_003 crossref_primary_10_1007_s11356_022_21812_8 crossref_primary_10_15585_mmwr_mm7148a3 crossref_primary_10_1016_j_heliyon_2023_e23792 crossref_primary_10_1089_mdr_2022_0212 crossref_primary_10_3389_fbioe_2020_00630 crossref_primary_10_1186_s13756_021_01004_8 crossref_primary_10_1017_ice_2023_241 crossref_primary_10_1016_j_ajic_2020_04_025 crossref_primary_10_1016_j_ijmmb_2020_10_023 crossref_primary_10_1128_CMR_00139_19 crossref_primary_10_1016_j_jhin_2018_05_019 crossref_primary_10_7759_cureus_30566 crossref_primary_10_21055_0370_1069_2023_4_91_95 crossref_primary_10_3390_hygiene3020010 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 5PM ACYCR |
DOI | 10.4014/jmb.1706.06034 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1738-8872 |
EndPage | 2220 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2221368 PMC12392026 29032643 10_4014_jmb_1706_06034 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Intramural FDA HHS grantid: FD999999 |
GroupedDBID | --- 29L 53G 5GY 9ZL AAYXX ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION DIK DU5 F5P FRP GX1 HZB JDI OK1 P2P RPM SDH TR2 CGR CUY CVF ECM EIF NPM 5PM MZR ZZE |
ID | FETCH-LOGICAL-c385t-c42a03651d36e39ba93e4aa7a5355e5fc1b4aa17e3a32b506bd9854ad2deb5263 |
ISSN | 1017-7825 |
IngestDate | Sun Mar 09 07:51:34 EDT 2025 Sat Aug 30 05:11:23 EDT 2025 Sun Aug 31 01:36:46 EDT 2025 Thu Apr 24 22:57:36 EDT 2025 Tue Jul 01 02:12:10 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | antiseptic benzalkonium chloride Burkholderia cenocepacia Bactericidal effects chlorhexidine gluconate |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c385t-c42a03651d36e39ba93e4aa7a5355e5fc1b4aa17e3a32b506bd9854ad2deb5263 |
PMID | 29032643 |
PageCount | 10 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2221368 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12392026 pubmed_primary_29032643 crossref_citationtrail_10_4014_jmb_1706_06034 crossref_primary_10_4014_jmb_1706_06034 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20171228 |
PublicationDateYYYYMMDD | 2017-12-28 |
PublicationDate_xml | – month: 12 year: 2017 text: 20171228 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of microbiology and biotechnology |
PublicationTitleAlternate | J Microbiol Biotechnol |
PublicationYear | 2017 |
Publisher | 한국미생물·생명공학회 |
Publisher_xml | – name: 한국미생물·생명공학회 |
SSID | ssj0061286 |
Score | 2.244959 |
Snippet | Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia... Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia... |
SourceID | nrf pubmedcentral pubmed crossref |
SourceType | Open Website Open Access Repository Index Database Enrichment Source |
StartPage | 2211 |
SubjectTerms | Anti-Infective Agents, Local - pharmacology Benzalkonium Compounds - pharmacology Burkholderia cenocepacia - drug effects Burkholderia cenocepacia - physiology Chlorhexidine - analogs & derivatives Chlorhexidine - pharmacology Microbial Viability - drug effects 생물학 |
Title | Effects of Extended Storage of Chlorhexidine Gluconate and Benzalkonium Chloride Solutions on the Viability of Burkholderia cenocepacia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29032643 https://pubmed.ncbi.nlm.nih.gov/PMC12392026 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002301533 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Microbiology and Biotechnology, 2017, 27(12), , pp.2211-2220 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6ISReEHc6LrIQEg9VSmLHuTxuU2Er2rSHDY2nyE4cGnVNUdVK2_4AP44_xTlx4ibdJg1ecjm13STn8_Fn-_iYkI9cSc_N_chRUcgdPxO4zUucO7GUUPciD-p65W1xHByc-eNzcd7r_Wl5La2Waphe37qu5H-0CjLQK66S_QfN2kJBANegXziChuF4Lx2P1s4Yo3owG6NrL6QZCdifQGd8oi-LDKnkV3ROL4FaVvMFe7q8lhfADovVzCQsMj2wg2T1HMLge2HieFfz8HurxRRnq_DVBqkuoemDHnch7yC4s2IjyBNcL2-M5O9OKrtXWR2lzUcyTgFm_bbGzZCOrvC04Tz0A0TOuFj7FBUnq5ls_IsH42F7RANaSc-uEDdGGGXAXMxstzayEAwzGMSO5TZRBRqEsrYdZrUJ1_VtteLuRnsBnUsf24uZGmIYoaEbuPXQaicw90aDad0YoQOFJSSQP8H8SZV_izxgYWh8Bg6_NbQAmGS17ah9ORNBFPN_7v5_hyFtlYu8RY66jrstJnT6hDyuNUx3DR6fkp4un5GHZlPTq-fkd41KOs9pg0paoxJlHVRSi0oKCKFtVNIGldSiks5LCqikFpVYXhuVtIXKF-Tsy-h0_8Cpt_twUh6JpZP6TAKfEl7GA81jJWOufSlDKYATa5GnnoJbL9RccqaEG6gsjoQvM5ZpJVjAX5Ltcl7q14QKyfyIazf1cu1HQa6YYG6oGMJCB8rvE6f5xElax8LHLVkukttV2iefbPpfJgrMnSk_gMaSaVokGLgdzz_nyXSRQPf0MMEH4EHUJ6-MHm1hLHahH-XzPok6GrYJsLDuL2UxqaLBA_WMmcuCnXs_4xvyaF3t3pLt5WKl3wG1Xqr3FWTheHxy9BfkhdRD |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Extended+Storage+of+Chlorhexidine+Gluconate+and+Benzalkonium+Chloride+Solutions+on+the+Viability+of+Burkholderia+cenocepacia&rft.jtitle=Journal+of+microbiology+and+biotechnology&rft.au=Ahn%2C+Youngbeom&rft.au=Kim%2C+Jeong+Myeong&rft.au=Lee%2C+Yong-Jin&rft.au=LiPuma%2C+John+J.&rft.date=2017-12-28&rft.issn=1017-7825&rft.eissn=1738-8872&rft.volume=27&rft.issue=12&rft.spage=2211&rft.epage=2220&rft_id=info:doi/10.4014%2Fjmb.1706.06034&rft.externalDBID=n%2Fa&rft.externalDocID=10_4014_jmb_1706_06034 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1017-7825&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1017-7825&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1017-7825&client=summon |